Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningHematopoietic Stem Cell MobilizationStem Cell TransplantationMelphalanHematologic NeoplasmsGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisAntigens, CD34Graft vs Host DiseaseBlood Component RemovalMultiple MyelomaCyclophosphamideMyeloablative AgonistsAntineoplastic Combined Chemotherapy ProtocolsBusulfanBone Marrow TransplantationTreatment OutcomeStem CellsGraft SurvivalHematopoietic Stem CellsLymphoma, Non-HodgkinRemission InductionEtoposideRecurrenceThiotepaAntineoplastic Agents, AlkylatingCarmustineCord Blood Stem Cell TransplantationTransplantation ChimeraSalvage TherapyCytophagocytosisTissue DonorsIfosfamideVincristineDisease-Free SurvivalAmyloidosisHematopoiesisCytarabineRetrospective StudiesHodgkin DiseaseWhole-Body IrradiationSurvival RateNeoplasmsSurvival AnalysisHistocompatibilityTime FactorsHistocompatibility TestingInfectionImmunosuppressive AgentsLiver TransplantationVidarabineLymphoma, T-CellLeukemia, Myeloid, AcuteDoxorubicinTransplantation, IsogeneicLeukemiaPlatelet CountPOEMS SyndromeGraft vs Leukemia EffectPrednisoneFollow-Up StudiesMesenchymal Stem Cell TransplantationCarboplatinDexamethasoneCytomegalovirus InfectionsBlood Cell CountAntineoplastic AgentsBone Marrow PurgingLymphomaProspective StudiesRecombinant ProteinsFatal OutcomeCell TransplantationMyelodysplastic SyndromesBlood CellsKidney TransplantationEmbryonic Stem CellsFeasibility StudiesAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionHematologic DiseasesHLA AntigensAdult Stem CellsImmunophenotypingPrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesImmunosuppressionPrognosisTransplantation ImmunologyCyclosporineOpportunistic InfectionsBlood Transfusion, AutologousBone MarrowCell Separation